Nova Pharma Group, in partnership with Zoetis, recently hosted an exclusive roundtable discussion focused on osteoarthritis and orthopedic conditions, bringing together veterinary professionals for an evening of valuable learning and exchange.

The event welcomed veterinarians from across the UAE, creating a collaborative environment to explore current approaches to diagnosis, treatment, and long-term management of orthopedic conditions in companion animals.

Advancing Clinical Perspectives in Osteoarthritis Management

The roundtable featured insightful discussions and practical clinical perspectives, with a strong emphasis on improving patient outcomes in both dogs and cats. The session highlighted the impact of Librela and Solensia, two innovative solutions redefining long-term approaches to osteoarthritis pain management. Through clinical case discussions, participants explored how these treatments deliver targeted, long-lasting pain relief, contributing to better patient outcomes.

Expert Insights and Knowledge Exchange

We were honored to welcome Dr.Stella Pantazopoulou, whose expertise added exceptional value to the session. Her contributions enriched the discussion, offering deeper insights into evolving treatment strategies and clinical best practices.

The roundtable format encouraged open dialogue, allowing veterinary professionals to exchange knowledge, share challenges, and align on practical approaches to orthopedic care in everyday practice.

Strengthening Expertise Through Collaboration

Such initiatives demonstrate Nova Pharma Group’s commitment to promoting veterinary learning and encouraging meaningful collaboration within the animal health sector.

Through fostering scientific dialogue, we support veterinary professionals in gaining the insights and tools needed to elevate standards of care and optimize patient outcomes.